The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kuriyel Ralf since 2018.
This trader's CIK number is 1733143.
At the time of last reporting, Kuriyel Ralf was the Senior VP, R&D of Repligen Corp. (stock ticker symbol RGEN).
Also see all insider trading activities at Repligen Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RGEN | 0 | $0 | 15,130 | $2,558,346 | 1,446 | $124,500 |
| 2022 | RGEN | 0 | $0 | 4,840 | $1,232,602 | 4,000 | $238,228 |
| 2021 | RGEN | 0 | $0 | 21,588 | $4,467,509 | 11,602 | $599,437 |
| 2020 | RGEN | 0 | $0 | 17,070 | $2,221,634 | 13,000 | $437,030 |
| 2019 | RGEN | 0 | $0 | 2,425 | $142,051 | 0 | $0 |
| 2018 | RGEN | 0 | $0 | 311 | $16,930 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-02 | RGEN | Option Ex | 175 | 86.10 | 15,067 |
| 2024-08-02 | RGEN | Sale | 7,148 | 159.10 | 1,137,282 |
| 2024-08-01 | RGEN | Sale | 4,465 | 165.67 | 739,716 |
| 2024-03-11 | RGEN | Option Ex | 1,271 | 86.10 | 109,433 |
| 2024-03-11 | RGEN | Sale | 3,517 | 193.73 | 681,348 |
| 2022-08-11 | RGEN | Option Ex | 4,000 | 59.56 | 238,228 |
| 2022-08-11 | RGEN | Sale | 4,840 | 254.67 | 1,232,602 |
| 2021-08-30 | RGEN | Sale | 4,001 | 282.13 | 1,128,802 |
| 2021-06-10 | RGEN | Option Ex | 3,602 | 72.81 | 262,261 |
| 2021-06-10 | RGEN | Sale | 6,802 | 189.19 | 1,286,870 |
| 2021-05-14 | RGEN | Sale | 710 | 172.29 | 122,325 |
| 2021-03-10 | RGEN | Option Ex | 8,000 | 42.15 | 337,176 |
| 2021-03-10 | RGEN | Sale | 8,000 | 191.18 | 1,529,440 |
| 2021-03-04 | RGEN | Sale | 2,075 | 192.81 | 400,072 |
| 2020-12-16 | RGEN | Sale | 435 | 186.18 | 80,988 |
| 2020-08-06 | RGEN | Option Ex | 5,000 | 33.87 | 169,350 |
| 2020-08-06 | RGEN | Sale | 5,000 | 153.79 | 768,950 |
| 2020-05-15 | RGEN | Sale | 435 | 140.69 | 61,200 |
| 2020-05-13 | RGEN | Option Ex | 8,000 | 33.46 | 267,680 |
| 2020-05-13 | RGEN | Sale | 8,000 | 127.82 | 1,022,536 |
| 2020-03-03 | RGEN | Sale | 450 | 88.35 | 39,757 |
| 2020-03-04 | RGEN | Sale | 2,555 | 90.53 | 231,316 |
| 2020-02-26 | RGEN | Sale | 195 | 86.60 | 16,887 |
| 2019-03-05 | RGEN | Sale | 2,240 | 58.53 | 131,107 |
| 2019-02-28 | RGEN | Sale | 185 | 59.16 | 10,944 |
| 2018-12-18 | RGEN | Sale | 311 | 54.44 | 16,930 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kuriyel Ralf (Senior VP, R&D of Repligen Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.